URI is an oncogene amplified in ovarian cancer cells and is required for their survival
about
URI promotes the migration and invasion of human cervical cancer cells potentially via upregulation of vimentin expression.Analysis of URI nuclear interaction with RPB5 and components of the R2TP/prefoldin-like complex.Investigating the utility of clinical outcome-guided mutual information network in network-based Cox regression.Identification of constrained cancer driver genes based on mutation timingRMP predicts survival and adjuvant TACE response in hepatocellular carcinoma.URI expression in cervical cancer cells is associated with higher invasion capacity and resistance to cisplatin.URI1 amplification in uterine carcinosarcoma associates with chemo-resistance and poor prognosis.The association of PI3 kinase signaling and chemoresistance in advanced ovarian cancer.Upregulation of URI/RMP gene expression in cervical cancer by high-throughput tissue microarray analysis.Boosting NAD(+) for the prevention and treatment of liver cancer.RMP plays distinct roles in the proliferation of hepatocellular carcinoma cells and normal hepatic cells.Expression analysis of URI/RMP gene in endometrioid adenocarcinoma by tissue microarray immunohistochemistryColorectal cancer cells display chaperone dependency for the unconventional prefoldin URI1.Synthetic lethality between CCNE1 amplification and loss of BRCA1.URI regulates tumorigenicity and chemotherapeutic resistance of multiple myeloma by modulating IL-6 transcription.Detection of CCNE1/URI (19q12) amplification by in situ hybridisation is common in high grade and type II endometrial cancer.Oncogenes associated with drug resistance in ovarian cancer.Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.Loss of the novel mitochondrial protein FAM210B promotes metastasis via PDK4-dependent metabolic reprogramming.CKAP4 inhibited growth and metastasis of hepatocellular carcinoma through regulating EGFR signaling.RMP promotes venous metastases of hepatocellular carcinoma through promoting IL-6 transcription.URI prevents potassium dichromate-induced oxidative stress and cell death in gastric cancer cells.RMP promotes epithelial-mesenchymal transition through NF-κB/CSN2/Snail pathway in hepatocellular carcinomaR2TP/Prefoldin-like component RUVBL1/RUVBL2 directly interacts with ZNHIT2 to regulate assembly of U5 small nuclear ribonucleoprotein.The viral oncoprotein HBx of Hepatitis B virus promotes the growth of hepatocellular carcinoma through cooperating with the cellular oncoprotein RMP.URI promotes gastric cancer cell motility, survival, and resistance to adriamycin in vitro.PDRG1 at the interface between intermediary metabolism and oncogenesis.URI knockdown induces autophagic flux in gastric cancer cells
P2860
Q33850336-C0CBB3E2-D694-4834-8B82-830649824735Q34718463-DBCA17F5-8EFB-4DCA-B472-1082712795F7Q35092859-8E14210B-61A7-4237-A519-0CC12D78502DQ35539823-83851607-3AAC-4781-AF04-F0DF6DAA1FD2Q35550266-5D485E75-C086-4986-8585-D2A8C14B50A5Q35757985-CED06BDF-551D-4D1D-9E3D-62121E3123FBQ35993195-7FF73B95-3C02-41CA-8312-544950FA51AEQ36242802-65026457-9BFA-4986-B498-75D4C86E2F8DQ36712017-28CFAEE4-BE42-4CFC-A1BF-51A83BD184C7Q36997932-8C1BB354-9AE4-4D2A-9212-0BD363D8182BQ37001528-7F162197-B078-490A-A6C5-8B0862FA1B01Q37277758-5142BC94-D297-44F1-AB18-2E1CD0D1A4BCQ37301900-FD78F9FA-03DD-45B8-847D-AB8B37C0EE38Q37353157-0D1568AB-87F3-4EFE-B86C-633DB0986218Q37680154-5A2A056C-CC0A-4D44-81F6-1E14F3959399Q37716446-FB8540A2-8470-438E-8F8D-F75C63934A96Q38226577-88B40DA3-89EE-4FC9-9CFD-E8DD985E30E5Q38727481-D2328B69-92DC-4D81-9DAE-3BBCAF228E35Q38736595-394499DF-D03B-476E-BEBC-DA1CDB9F55FDQ38993980-84F94553-3487-44A6-880D-FACBBFE7C417Q39007383-70C8CD81-4BCA-4D8C-B893-CAACF1169E89Q40634038-C69D4D9D-AF03-403D-94EC-5FEA4CE6440FQ41092894-A1534F18-69AC-4CD8-AC4D-62968C9B9611Q41788699-098D1CA0-6615-49E1-8910-39DBC7A67E3DQ41870930-55D89063-1DC7-48F1-9958-0B4D3696AFA1Q42428140-41AB4335-ECC1-4F50-A902-A6B061B8F449Q47138661-D35E3EE5-69EB-47EA-AB74-62734FF4DB42Q58790027-241BF832-B351-4E7A-B36E-958ADA775A80
P2860
URI is an oncogene amplified in ovarian cancer cells and is required for their survival
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
URI is an oncogene amplified in ovarian cancer cells and is required for their survival
@ast
URI is an oncogene amplified in ovarian cancer cells and is required for their survival
@en
URI is an oncogene amplified in ovarian cancer cells and is required for their survival
@en-gb
URI is an oncogene amplified in ovarian cancer cells and is required for their survival
@nl
type
label
URI is an oncogene amplified in ovarian cancer cells and is required for their survival
@ast
URI is an oncogene amplified in ovarian cancer cells and is required for their survival
@en
URI is an oncogene amplified in ovarian cancer cells and is required for their survival
@en-gb
URI is an oncogene amplified in ovarian cancer cells and is required for their survival
@nl
prefLabel
URI is an oncogene amplified in ovarian cancer cells and is required for their survival
@ast
URI is an oncogene amplified in ovarian cancer cells and is required for their survival
@en
URI is an oncogene amplified in ovarian cancer cells and is required for their survival
@en-gb
URI is an oncogene amplified in ovarian cancer cells and is required for their survival
@nl
P2093
P50
P3181
P1433
P1476
URI is an oncogene amplified in ovarian cancer cells and is required for their survival
@en
P2093
Alex Soltermann
Anna-Kathrin Zimmermann
Holger Moch
Marianne Helbling
Nico Henzi
Rosmarie Caduff
Stefan Christian Metzler
Wilhelm Krek
P304
P3181
P356
10.1016/J.CCR.2011.01.019
P407
P577
2011-03-08T00:00:00Z